US Patent 8003598 Peptide anti-tumor agent

Patent 8003598 was granted and assigned to New York University on August, 2011 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Current Assignee

New York University

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

80035980

Patent Inventor Names

Martin Jay Rosenberg0

Date of Patent

August 23, 2011

Patent Application Number

126478990

Date Filed

December 28, 2009

Patent Primary Examiner

‌

Maury Audet

Patent abstract

Disclosed herein are isolated, purified peptides, biologically active fragments and analogs of the peptides having anti-tumor activity in mammals, pharmaceutical formulations comprising the peptides, fragments and analogs and methods of treating mammals suffering from tumors using such materials.